SciSparc (SPRC) announced that the stockholders of N2OFF (NITO) voted on and approved, among other things, the proposed acquisition of SciSparc’s majority owned subsidiary, MitoCareX Bio Ltd.. This important milestone, achieved at N2OFF’s special meeting of stockholders held on September 25, clears a key path for the completion of the acquisition, which would result in MitoCareX becoming a wholly owned subsidiary of N2OFF.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SPRC: